Chronic obstructive pulmonary disease(COPD) poses a serious threat to human health, making it one of the major global public health burdens. In 2023, an expert consensus group was established to address key clinical questions in the integrated Chinese and western medicine management of COPD. Based on authoritative domestic and international guidelines and adapted to China's national conditions, the Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) was developed and published. To provide more scientific and practical guidance, a guideline development working group was formed as a project of the China Association of Chinese Medicine, with funding from multiple projects. The group integrated evidence-based medicine with expert experience and clinical realities, conducted systematic evidence retrieval and evidence grading, and ultimately developed the Guidelines for Integrated Traditional Chinese and Western Medicine in the Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2025 Edition). This guideline introduces the selection of screening tools for COPD at primary healthcare institutions. Focusing on integrative strategies for prevention and treatment of COPD, this guideline addresses 8 core clinical questions and provides specific recommendations on various interventions, including population screening, oral Chinese medicine, external therapies, and traditional Chinese exercises. This guideline emphasizes the organic integration of Chinese and western medicine in the diagnosis and treatment of COPD, with a focus on individualized therapy, aiming to further enhance the comprehensive diagnosis, treatment, and management of COPD in China.